This new vaccine approach, described May 1 in the journal Science Translational Medicine, is part of a 5-year-old effort to ...

A Dutch man with the longest case of COVID infection ever recorded suffered from the sickness for a record 613 days, with the ...

A universal vaccine would train the body to recognize and eradicate new viral strains, even if they've mutated into nearly ...

An immune-compromised man with a year-and-a-half-long COVID-19 infection served as a breeding ground for dozens of ...

Current influenza vaccines are only about 40% effective because viruses can mutate rapidly and escape immune surveillance ...

T cells are integral in the immune system but can become "dysfunctional inside tumors." "The approval of Amtagvi represents ...

NanoViricides, Inc. (NYSE Amer:NNVC) (the “Company”), a global leader in broad-spectrum antiviral nanomedicines, reports that ...

A new case study of a 72-year-old man from the Netherlands who had a sustained COVID-19 infection for nearly two years shows ...

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an ...

May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21.

Hope is at hand, however, in the form of immunotherapy. The most acute hay fever sufferers are sometimes referred for the ...

Good day, and thank you for standing by, and welcome to the Corcept Therapeutics conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like ...